The St. Jude Children's Research Hospital Comprehensive Cancer Center (SJCCC) Clinical Trials Scientific Review Committee (CT-SRC) serves as the internal, expert body responsible for reviewing the scientific rationale, feasibility, and study design of all clinical research protocols opened within the SJCCC. As an additional and related function, the CT-SRC monitors the progress of all SJCCC protocols, ensuring that they adhere to the approved study design;achieve their accrual goals in a timely manner;adhere to approved stopping criteria;and that patient safety is maintained. The CT-SRC has the authority to recommend protocol modifications and to close studies. The CT-SRC works in close collaboration with the other clinical trials oversight committees within the SJCCC including the IRB. Together, these complementary but non-overlapping bodies ensure the appropriate and safe conduct of high-quality clinical research within the SJCCC. Administratively, the CT-SRC is coordinated through the Central Protocol Data and Monitoring Office (CPDMO). The CT-SRC serves as the final step in a significant, formal, clinical trials concept development process within the SJCCC. The initial responsibility for developing high-quality, appropriately designed clinical trials lies at the level ofthe SJCCC Programs. To this end, each of our Programs that treat patients run clinical trial development efforts that invest great time and effort in protocol development prior to central review. To further enhance the efficient development of clinical trials by the SJCCC Programs, in July of 2012, the CT-SRC implemented a Concept review process for all SJCCC. investigator initiated studies. Additional changes made in the grant cycle period include adoption of a risk-based model for monitoring of clinical trials, formalizing a policy for accruals monitoring by the CT-SRC, and strengthening the committee membership with additional senior researchers. In summary, the SJCRH Protocol Review and Monitoring System evaluates and monitors all prospective clinical trials for scientific merit and alignment with the goals of the SJCCC.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA021765-35
Application #
8634437
Study Section
Subcommittee G - Education (NCI)
Project Start
1997-04-01
Project End
2019-02-28
Budget Start
2014-06-09
Budget End
2015-02-28
Support Year
35
Fiscal Year
2014
Total Cost
$239,881
Indirect Cost
$103,873
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
067717892
City
Memphis
State
TN
Country
United States
Zip Code
38105
Schulte, Fiona; Brinkman, Tara M; Li, Chenghong et al. (2018) Social adjustment in adolescent survivors of pediatric central nervous system tumors: A report from the Childhood Cancer Survivor Study. Cancer 124:3596-3608
Wu, Gang; Fan, Liying; Edmonson, Michael N et al. (2018) Inhibition of SF3B1 by molecules targeting the spliceosome results in massive aberrant exon skipping. RNA 24:1056-1066
Ganguly, Samit; Panetta, John C; Roberts, Jessica K et al. (2018) Ketamine Pharmacokinetics and Pharmacodynamics Are Altered by P-Glycoprotein and Breast Cancer Resistance Protein Efflux Transporters in Mice. Drug Metab Dispos 46:1014-1022
Pinto, Emilia M; Hamideh, Dima; Bahrami, Armita et al. (2018) Malignant rhabdoid tumors originating within and outside the central nervous system are clinically and molecularly heterogeneous. Acta Neuropathol 136:315-326
Upadhyaya, Santhosh A; McGee, Rose B; Wilky, Breelyn A et al. (2018) Malignant progression of a peripheral nerve sheath tumor in the setting of rhabdoid tumor predisposition syndrome. Pediatr Blood Cancer 65:e27030
Klosky, James L; Lehmann, Vicky; Flynn, Jessica S et al. (2018) Patient factors associated with sperm cryopreservation among at-risk adolescents newly diagnosed with cancer. Cancer 124:3567-3575
Gibson, Todd M; Mostoufi-Moab, Sogol; Stratton, Kayla L et al. (2018) Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol 19:1590-1601
Coustan-Smith, Elaine; Song, Guangchun; Shurtleff, Sheila et al. (2018) Universal monitoring of minimal residual disease in acute myeloid leukemia. JCI Insight 3:
Walker, Breya; Conklin, Heather M; Anghelescu, Doralina L et al. (2018) Parent perspectives and preferences for strategies regarding nonsedated MRI scans in a pediatric oncology population. Support Care Cancer 26:1815-1824
Hanna, Jason A; Garcia, Matthew R; Lardennois, Alicia et al. (2018) PAX3-FOXO1 drives miR-486-5p and represses miR-221 contributing to pathogenesis of alveolar rhabdomyosarcoma. Oncogene 37:1991-2007

Showing the most recent 10 out of 6764 publications